U.S. Markets closed

Summary Box: New J&J CEO takes reins Thursday

The Associated Press

ON DECK: Johnson & Johnson CEO Bill Weldon is stepping down after a decade and vice chairman Alex Gorsky will take over at J&J's annual meeting Thursday.

OPTIMISTIC OUTLOOK: Gorsky sees the health giant as well-positioned to produce innovative new medicines and other products that patients need. He expects to complete a $21-billion deal to buy an orthopedic device maker.

REALISTIC ON PROBLEMS: Gorsky is focused on getting dozens of recalled consumer health products back on the market, restoring consumer confidence and resolving legal and ethical issues while also making deals to expand J&J.